Hepatitis C virus: Epidemiology, transmission and prevention

Current Studies in Hematology and Blood Transfusion

Volumn 62, Issue , 1998, Pages 208-236

  Van Der Poel, Cees L ^a   Ebeling, Freja ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; FEMALE; HEALTH CARE PERSONNEL; HEMODIALYSIS PATIENT; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; SEXUALITY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HEPATITIS E; HUMANS; INCIDENCE; RISK FACTORS;

EID: 0031884766     PISSN: 02580330     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060480     Document Type: Article

References (217)

1. Blumberg BS, Gerstley BJS, Hungerford DA, et al: A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Ann Intern Med 1967;66:924-931.
2. Feinstone SM, Kapikian AZ, Purcell RH: Hepatitis A: Detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 1973;182:1026-1028.
3. Prince AM, Brotman B, Grady GF, et al: Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis B virus. Lancet 1974;ii:241-246.
4. Alter HJ, Purcell RH, Holland PV, et al: Clinical and serological analysis of transfusion associated hepatitis. Lancet 1975;ii:838-841.
5. Reesink HW, Van der Poel CL: Blood transfusion and hepatitis: Still a threat? Blut 1989:58:1-6.
6. Reesink HW, Leentvaar-Kuypers A, Van der Poel CL, et al: Non-A, non-B posttransfusion hepatitis in open heart surgery patients in The Netherlands: Preliminary results of a prospective study; in Zuckerman AJ (ed): Viral Hepatitis and Liver Disease. New York, Liss, 1988, pp 558-560.
7. Alter HJ, Purcell RH, Holland PV, et al: Donor transaminase and recipient hepatitis. JAMA 1981; 246:630-634.
8. Dienstag JL: Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 1983;85:439-462.
9. Alter MJ, Gerety RJ, Smallwood LA, et al: Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban US population. J Infect Dis 1982;145:886-893.
10. Alter MJ, Coleman PJ, Alexander WJ, et al: Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1201-1205.
11. Kurhoo MS: Study of an epidemic of non-A, non-B hepatitis: Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818-824.
12. Reyes GR, Purdy MA, Kim JP, et al: Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335-1339.
13. Kurhoo MS, Teli MR, Skidmore S, et al: Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252-255.
14. Ramalingaswami V, Purcell RH: Waterborne non-A, non-B hepatitis. Lancet 1988;ii:571-573.
15. Zaaijer HL, Yin MF, Lelie PN: Seroprevalence of hepatitis E in the Netherlands. Lancet 1992;340: 12.
16. Aach RD, Szmuness W, Mosley JW, et al: Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 1981;304:989-993.
17. Linen J, Wges J, Zhang-Keck ZY, et al: Molecular cloning and disease association of hepatitis G virus: A transfusion transmissible agent. Science 1996;271:505-508.
18. Alter HJ: The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996;334: 1536-1537.
19. Zuck TF, Sherwood WC, Bove JR: A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis. Transfusion 1987;27:203-206.
20. Stevens CE, Aach RD, Hollinger FB, et al: Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. Ann Intern Med 1984;101:733-738.
21. Koziol DE, Holland PV, Alling DW, et al: Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104: 488-495.
22. Widell A, Sundström G, Hansson BG, et al: Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden. Vox Sang 1988;54:154-159.
23. Aymard JF, Janot C, Gayet S, et al: Posttransfusion non-A, non-B hepatitis after cardiac surgery. Vox Sang 1986;51:236-238.
24. Choo Q-L, Kuo G, Weiner AJ, et al: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
25. Van der Poel CL, Reesink HW, Lelie PN, et al: Anti-hepatitis C antibodies and non-A, non-B posttransfusion hepatitis in The Netherlands. Lancet 1989;ii:297-298.
26. Van der Poel CL, Reesink HW, Schaasberg W, et al: Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990;335:558-560.
27. Esteban JI, Gonzales A, Hernandez JM, et al: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-1112.
28. Alter HJ, Purcell RH, Shih JW, et al: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321:1495-1500.
29. Van der Poel CL, Cuypers MTH, Reesink HW, et al: Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991;337:317-319.
30. Van der Poel CL, Bresters D, Reesink HW, et al: Early anti-hepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang 1992;62:208-212.
31. Contreras M, Barbara JAJ, Anderson CC, et al: Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet 1991;337:753-757.
32. Brind AM, Codd AA, Cohen BJ, et al: Low prevalence of antibody to hepatitis C virus in North East England. J Med Virol 1990;32:243-248.
33. Kühnl P, Seidl S, Stangel W, et al: Antibody to hepatitis C virus in German blood donors. Lancet 1989;ii:324.
34. Esteban JI, González A, Hernández JM, et al: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990;323:1107-1112.
35. Pår A: Antibodies to hepatitis C virus in Hungary. Lancet 1990;336:123.
36. Janot C, Couroucé AM, Maniez M: Antibodies to hepatitis C virus in French blood donors. Lancet 1989;ii:796-797.
37. Sirchia G, Bellobuono A, Giovanetti A, et al: Antibodies to hepatitis C virus in Italian blood donors. Lancet 1989;ii:797.
38. Miyamura T, Saito I, Katayama T, et al: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci 1990;87:983-987.
39. Katayama T, Kikuchi S, Tanaka Y, et al: Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion 1990;30:374-376.
40. Nishioka K, Watanabe J, Furuta S, et al: A high prevalence of antibody to hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-433.
41. Watanabe J, Minegishi K, Mitsumori T, et al: Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 1990;59:86-88.
42. Weiner AJ, Truett MA, Rosenblatt J, et al: HCV testing in low-risk populations. Lancet 1990;336: 695.
43. Mimms L, Vallari D, Ducharme L, et al: Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet 1990;336:1590-1591.
44. Dawson GJ, Lesniewski RR, Stewart JL, et al: Detection of antibody to hepatitis C virus in US blood donors. J Clin Microbiol 1991;29:551-556.
45. Van der Poel CL, Cuypers HTM, Reesink HW, et al: Risk factors in HCV infected blood donors. Transfusion 1991;31:777-779.
46. Garson JA, Clewley JP, Simmonds P, et al: Hepatitis C viraemia in United Kingdom blood donors. Vox Sang 1992;62:218-223.
47. Allain JP, Rankin A, Kuhns MC, et al: Clinical importance of HCV confirmatory testing in blood donors. Lancet 1992;339:1171-1172.
48. Follet EAC, Dow BC, McOmish F, et al: HCV confirmatory testing of blood donors. Lancet 1991; 338:1024.
49. Löve A, Smaradottir A, Thorsteinsson SB, et al: Hepatitis C virus genotypes among blood donors and their recipients in Iceland determined by polymerase chain reaction. Vox Sang 1995;69:18-22.
50. Caspari G, Gerlich WH, Beyer J, et al: Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors. Infusionsther Transfusionsmed 1995;22:208-219.
51. Burin des Roziers, Nasr O: Second generation anti-HCV tests and surrogate markers in volunteer blood donors. Transfusion 1992;32:492.
52. Munoz Gomez R, Garcia-Monzon C: Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Eur J Gastroenterol Hepatol 1996;8:273-277.
53. Stern M, Manny N, Klein A, et al: A study of Israeli blood donors, asymptomatic carriers of hepatitis C virus, in relation to liver disease, cryoglobulinemia and transmission. Isr J Med Sci 1995;3:277-279.
54. Saeeed AA, Ahmed MA, Abdulmohsin AR, et al: Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991;338:459-460.
55. Arankalle VA, Tungatkar SP, Banerjee K: Anti-HCV positivity among blood donor population from Puna, India (1981-1994). Vox Sang 1996;69:75.
56. Wu RR, Mizokami M, Lau JY, et al: Seroprevalence of hepatitis C virus infection and its genotype in Lanzhou, western China. J Med Virol 1995;45:174-178.
57. Sawanpanyalert P, Boonmar S, Maeda T, et al: Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand. J Epidemiol Community Health 1996;50: 174-177.
58. Archer GT, Buring ML, Clark B, et al: Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992;157:225-227.
59. Ilako FM, McLigeyo SO, Riyat MS, et al: The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J 1995;72: 362-364.
60. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A, et al: Antibodies to hepatitis C virus: A cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol 1995;7:237-241.
61. Maclennan S, Barbara JA, Hewitt P, et al: Screening blood donations for HCV. Lancet 1992;339: 131-132.
62. Moore SB, Kruger JR, Rakela J, et al: Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: Evidence of failure to identify some risk factors. Transfusion 1995;35:308-312.
63. Kolho EK, Krusius T: Risk factors for hepatitis C virus antibody positivity in blood donors in a low risk country. Vox Sang 1992;63:192-197.
64. Conry-Cantilena C, Viladomiu L, Melpolder J, et al: Risk factors for hepatitis C virus infection in a US urban donor population. Transfusion 1992;32(suppl):S46.
65. Kaldor JM, Arhcer GT, Buring ML, et al: Risk factors for hepatitis C virus infection in blood donors: A case-control study. Med J Aust 1992;157:227-230.
66. Neal KR, Jones DA, Killey D, et al: Risk factors for hepatitis C virus infection: A case-control study of blood donors in the Trent region (UK). Epidemiol Infect 1994;112:595-601.
67. Murphy EL, Bryzman S, Williams AE, et al: Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000.
68. Zuck TF, Rose GA, Dumaswala UJ, et al: Experience with a transfusion recipient education program about hepatitis C. Transfusion 1990;30:759-761.
69. Van der Poel CL, Reesink HW, Mauser-Bunschoten EP, et al: Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands. Vox Sang 1991;61:30-36.
70. Vrielink H, Van der Poel CL, Reesink HW, et al: Look-back study of infectivity of anti-HCV ELISA positive blood components. Lancet 1995;345:95-96.
71. Schreiber GB, Busch MP, Kleinman SH, et al: The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
72. Meisel H, Reip A, Faltus B, et al: Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 1995;345:1209-1211.
73. Power JP, Lawlor E, Davidson F, et al: Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-1213.
74. Roussell RH, Budinger MD, Pirofsky B, et al: Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25. Vox Sang 1991;60:65-68.
75. Hatzakis A, Polychronaki H, Miriagou V, et al: Antibody responses to hepatitis C virus by second generation immunoassays in a cohort of patients with bleeding disorders. Vox Sang 1992;63: 204-209.
76. Williams PE, Yap PL, Gillon J, et al: Non-A, non-B hepatitis transmission by intravenous immunoglobulin. Lancet 1988;ii:501.
77. Donegani E, Di Summa M, Bobbio M, et al: Safety of anti-HCV-reactive immunoglobulin in heart transplant patients. Lancet 1992;340:1039.
78. Ward KN, Morgan G, Ashworth K, et al: Spurious outbreak of HCV in bone-marrow recipients treated with cytomegalovirus immunoglobulin. Lancet 1992;340:1290-1291.
79. Dodd RY: Hepatitis C virus, antibodies and infectivity: Paradox, pragmatism and policy. Am J Clin Pathol 1992;97:4-6.
80. Lefrere JJ, Loiseau P, Martinot-Peignoux M, et al: Infection by hepatitis C virus through contaminated intravenous immune globulin: Results of a prospective national inquiry in France. Transfusion 1996;36:394-397.
81. Lee C: Transfusion-transmitted disease. Baillières Clin Haematol 1996;9:369-394.
82. Mauser-Bunschoten EP, Bresters D, van Drimmelen AAJ, et al: Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995;45:241-246.
83. Jarvis LM, Ludlam CA, Ellender JA, et al: Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. Blood 1996;87:3007-3011.
84. Tuveri R, Rothschild C, Pol S, et al: Hepatitis C virus genotypes in haemophiliacs: Kinetics and reappraisal of mixed infections. J Med Virol 1997;51:36-41.
85. Telfer P, Sabin C, Devereux H, et al: The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994;87:555-561.
86. Tagariello G, Pontisso P, Davoli PG, et al: Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs. Br J Haematol 1995;91:708-713.
87. Makris M, Preston FE, Rosendaal FR, et al: The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996;94:746-752.
88. Esteban JI, Esteban R, Viladomiu L, et al: Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;ii:294-296.
89. Mortimer PP, Cohen BJ, Litton PA, et al: Hepatitis C virus antibody. Lancet 1989;ii:798.
90. Smyth R, Keenan E, Dorman A, O'Connor J: Hepatitis C infection among injecting drug users attending the National Drug Treatment Centre. Isr J Med Sci 1995;164:267-268.
91. Bolumar F, Hernandez-Aguado I, Ferrer L, et al: Prevalence of antibodies to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992. Int J Epidemiol 1996;25:204-209.
92. Cilia G, Garcia-Bengoechea M, Perez-Trallero E, et al: Genotyping of hepatitis C virus isolates from Basque Country, Spain. Epidemiol Infect 1996;117:533-536.
93. Stark K, Schreier E, Muller R, et al: Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 1995;27:331-337.
94. Allander T, Medin C, Jacobson SH, et al: Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43: 415-419.
95. Sampietro M, Baddalamenti S, Salvadori S, et al: High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995;47:911-917.
96. DeLamballerie X, Olmer M, Bouchouareb D, et al: Nosocomial transmission of hepatitis C virus in haemodialysis patients. J Med Virol 1996;49:296-302.
97. Fabrizi F, Lunghi G, Guarnori I, et al: Hepatitis C virus genotypes in chronic dialysis patients. Nephrol Dial Transplant 1996;11:679-683.
98. Stuyver L, Claeys H, Wyseur A, et al: Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission. Kidney Int 1996;49:889-895.
99. Pru CE, Cuervo C, Ardila M, Teran M: Hepatitis C transmission through dialysis machines. ASAIO J 1994;40:M889-M891.
100. Blumberg A, Zehnder C, Burckhardt JJ: Prevention of hepatitis C infection in haemodialysis units. A prospective study. Nephrol Dial Transplant 1995;10:230-233.
101. Caramelo C, Navas S, Alberola ML, et al: Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994;66:470-473.
102. Hubmann R, Zazgornik J, Gabriel C, et al: Hepatitis C virus - Does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 1995;10:541-542.
103. Manzini P, Amore A, Bonaudo R, et al: L'RNA dell'HCV e riscontrabile nell'ultrafiltrato? Minerva Urol Nefrol 1996;48:75-79.
104. Okuda K, Hayashi H, Kobayashi S, Irie Y: Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995;23:28-31.
105. Fabrizi F, Lunghi G, Guarnori I, et al: Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant 1994;9:1611-1615.
106. Huraib S, al-Rashed R, Aldrees A, et al: High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 1995;10:470-474.
107. Gilli P, Soffritti S, De Paoli-Vitali E, Bedani PL: Prevention of hepatitis C virus in dialysis units. Nephron 1995;70:301-306.
108. Esteban JI, Gómez J, Martell M, et al: Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-560.
109. Allander T, Gruber A, Naghavi M, et al: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-607.
110. Schvarcz R, Nyström B, Oksanen A, Sönnerborg A: Prevention of nosocomial transmission of hepatitis C virus. Lancet 1995;346:190.
111. Ragg M: Transmission of hepatitis C via anaesthetic tubing? Lancet 1994;343:1419.
112. Piazza M, Borgia G, Picciotto L: Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. J Med Virol 1995;45:40-42.
113. Porter SR, Lodi G: Hepatitis C virus (HCV) - An occupational risk to dentists? Br Dent J 1996; 180:473-474.
114. Zuckerman J, Clewley G, Griffiths P, Cockcroft A: Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 1994;343:1618-1620.
115. Petrosillo N, Puro V, Ippolito G, et al: Prevalence of hepatitis C antibodies in health-care workers. Lancet 1994;344:339-340.
116. Arai Y, Noda K, Enomoto N, et al: A prospective study of hepatitis C virus infection after needlestick accidents. Liver 1996;16:331-334.
117. Gerberding JL: Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-451.
118. Neal KR, Dornan J, Irving WL: Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals: Who is at risk? Br Med J 1997;314:179-180.
119. Struve J, Aronsson B, Frenning B, et al: Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm. Scand J Gastroenterol 1994;29:360-362.
120. Germanaud J, Barthez JP, Causse X: The occupational risk of hepatitis C infection among hospital employees. Am J Public Health 1994;84:122.
121. Maillard MF, Poynard T, Dubreuil P, et al: Prevalence of anti-HCV antibodies in the personnel of the Antoine-Beclere Hospital. Gastroenterol Clin Biol 1996;20:1053-1057.
122. Vanderborght BO, Rouzere C, Ginuino CF, et al: High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: A one-year follow-up study. Rev Inst Med Trop Sao Paulo 1995;37:75-79.
123. Frider B, Sookoian S, Castano G, et al: Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays. Acta Gastroenterol Latinoam 1994;24:71-75.
124. Gerberding JL: Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. J Infect Dis 1994;170:1410-1417.
125. Panlilio AL, Shapiro CN, Schable CA, et al: Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. J Am Coll Surg 1995;180: 16-24.
126. Goetz AM, Ndimbie OK, Wagener MM, Muder RR: Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 1995;59:990-994.
127. Schlipköter U, Gladziwa U, Cholmakov K, et al: Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a 2nd generation enzyme-linked immunosorbent assay. Med Microbiol Immunol 1992;181:173-180.
128. Jadoul M, El Akrout M, Cornu C, et al: Prevalence of hepatitis C antibodies in health-care workers. Lancet 1994;344:339.
129. Tokars JI, Alter MJ, Favero MS, et al: National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J 1994;40:1020-1031.
130. Fujiyama S, Kawano S, Sato S, et al: Changes in prevalence of anti-HCV associated with preventive measures among hemodialysis patients and dialysis staff. Hepatogastroenterology 1995;42:162-165.
131. Ribero ML, Tagger A, Testori T, et al: Prevalence of HCV antibody among Italian dental practitioners (abstract). Third Int Symp HCV, Strasbourg, 1991, p 96.
132. Klein RS, Freeman K, Taylor PE, Stevens CE: Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991;338:1539-1542.
133. Kudesia G, Ball G, Irving WL: Vertical transmission of hepatitis C. Lancet 1995;345:1122.
134. Power J, Davidson F, O'Riordan J, Simmonds P, Yap PL, Lawlor E: Hepatitis C infection from anti-D immunoglobulin. Lancet 1995;346:372-373.
135. Floreani A, Paternoster D, Zappala F, et al: Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol 1996;103:325-329.
136. Maggiore G, Ventura A, De Giacomo C, et al: Vertical transmission of hepatitis C. Lancet 1995; 345:1122.
137. Palomba E, Manzini P, Fiammengo P, et al: Natural history of perinatal hepatitis C virus infection. Clin Infect Dis 1996;23:47-50.
138. Ohio H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie N, Endo C, Matsui A, Okamoto H, Mishiro S, Vertical Transmission of Hepatitis C Virus Collaborative Study Group: Transmission of hepatitis C virus from mother to infants. N Engl J Med 1994;330:744-750.
139. Giacchino R, Picciotto A, Tasso L, et al: Vertical transmission of hepatitis C. Lancet 1995;345: 1122-1123.
140. Zuccotti GV, Ribero ML, Giovannini M, et al: Effect of hepatitis C genotype on mother-to-infant transmission of virus. J Pediatr 1995;127:278-280.
141. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, D'Amico E, Cambiè G, Vecchi L, Lombardy Study Group on Vertical HCV Transmission: Mother-to-infant transmission of hepatitis C virus. Lancet 1995;345:289-291.
142. Resti M, Azzari C, Lega L, et al: Mother-to-infant transmission of hepatitis C virus. Acta Paediatr 1995;84:251-255.
143. Sabatino G, Ramenghi LA, diMarzio M, Pizzigallo E: Vertical transmission of hepatitis C virus: An epidemiological study on 2,980 pregnant women in Italy. Eur J Epidemiol 1996;12:443-447.
144. Fischler B, Lindh G, Lindgren S, et al: Vertical transmission of hepatitis C virus infection. Scand J Infect Dis 1996;28:353-356.
145. Pipan C, Amici S, Astori G, et al: Vertical transmission of hepatitis C virus in low-risk pregnant women. Eur J Clin Microbiol Infect Dis 1996;15:116-120.
146. Lin HH, Kao JH, Hsu HY, et al: Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994;169:638-641.
147. Aizaki H, Saito A, Kusakawa I, et al: Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region. J Hepatol 1996;25:608-613.
148. Matsubara T, Sumazaki R, Takita H: Mother-to-infant transmission of hepatitis C virus: A prospective study. Eur J Pediatr 1995;154:973-978.
149. Ni YH, Lin HH, Chen PJ, et al: Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection. J Hepatol 1994;20:641-645.
150. Lin HH, Kao JH, Hsu HY, et al: Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996;87:244-248.
151. Giorlandino C, Gambuzza G, D'alessio P, Morgani AR: Neonatal blood tests to exclude caesarean section as a cause of maternal-fetal transmission of hepatitis C. Lancet 1995;346:908.
152. Zimmermann R, Perucchini D, Fauchère JC, Joller-Jemelka H, Geyer M, Huch R, Huch A: Hepatitis C virus in breast milk. Lancet 1995;345:928.
153. Lin HH, Kao JH, Hsu HY, et al: Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 1995;126:589-591.
154. Demelia L, Vallebona E, Poma R, et al: HCV transmission in family members of subjects with HCV related chronic liver disease. Eur J Epidemiol 1996;12:45-50.
155. Puoti C, Magrini A, Filippi T, Aldegheri L: Do symptomless HCV carriers spread infection to their relatives? Lancet 1995;346:843.
156. Klarmann D, Kreuz W, Auberger K, et al: Patient-to-patient transmission of hepatitis C virus. Lancet 1995;345:1444-1445.
157. Hou CH, Chen WY, Kao JH, et al: Intrafamilial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 1995;45:381-385.
158. Goto M, Fujiyama S, Kawano SI, et al: Intrafamilial transmission of hepatitis C virus. J Gastroenterol Hepatol 1994;9:13-18.
159. Seeff LB, Alter HJ: Spousal transmission of the hepatitis C virus? Ann Intern Med 1994;120:807-809.
160. Win N, Frame D, Watkins R, Mitchell R: The low risk of hepatitis C virus transmission among sexual partners of confirmed HCV-positive blood donors. Transfus Med 1994;4:243-245.
161. Bresters D, Mauser-Bunschoten EP, Reesink HW, et al: Sexual transmission of hepatitis C virus. Lancet 1993;342:210-211.
162. Mauser-Bunschoten EP: Complications of Hemophilia Care, PhD thesis. Utrecht University, 1995.
163. Davis AR, Kowalik AM: Hepatitis C virus transmission to heterosexual partners: Bedroom or bathroom hazard? Med J Aust 1996;164:126.
164. Gordon SC, Patel AH, Culesza GW, et al: Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 1992;87:1849-I851.
165. Tumminelli F, Marvellin P, Rizzo S, Barbera S, Corvino G, Furia P, Benhamou JP, Erlinger S: Shaving as a potential source of hepatitis C virus infection. Lancet 1995;345:658.
166. Kolho E, Naukkarinen R, Ebeling F, et al: Transmission of hepatitis C virus to sexual partners of seropositive patients with bleeding disorders: A rare event. Scand J Infect Dis 1991;23:667-670.
167. Brettler DB, Mannucci PM, Gringeri A, et al: The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: An international, multicenter study. Blood 1992;80:540-543.
168. Scotto G, Savastano AM, Fazio V, et al: Sexual transmission of hepatitis C virus infection. Eur J Epidemiol 1996;12:241-244.
169. Diago M, Zapater R, Tuset C, et al: Intrafamily transmission of hepatitis C virus: Sexual and non-sexual contacts. J Hepatol 1996;25:125-128.
170. Akahane Y, Kojima M, Sugai Y, et al: Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994;120:748-752.
171. Thomas DL, Zenilman JM, Alter HJ, et al: Sexual transmission of hepatitis C virus among patients attending sexually transmitted disease clinics in Baltimore - An analysis of 309 sex partnerships. J Infect Dis 1995;171:768-775.
172. Setoguchi Y, Kajihara S, Hara T, et al: Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs. J Gastroenterol Hepatol 1994;9:468-471.
173. Widell A, Shev S, Mansson S, et al: Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications. J Med Virol 1994; 44:272-279.
174. Hsu HH, Wright TL, Luba D, et al: Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology 1991;14:763-767.
175. Terada S, Kawanishi K, Katayama K: Minimal hepatitis C infectivity in semen. Ann Intern Med 1992;117:171-172.
176. Fiore RJ, Potenza D, Monno L, et al: Detection of HCV RNA in serum and seminal fluid from HIV-1 co-infected intravenous drug addicts. J Med Virol 1995;46:364-367.
177. Kuo G, Choo Q-L, Alter HJ, et al: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
178. Tremolada F, Casarin C, Tagger A, et al: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991;114:277-281.
179. Blajchman MA, Bull SB, Feinman SV: Post-transfusion Hepatitis: Impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group. Lancet 1995;345: 21-25.
180. Colombo M, Kuo G, Choo Q-L, et al: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;ii:1006-1008.
181. Barrera JM, Francis B, Ercilla G, et al: Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995;68:15-18.
182. Lee SR, Wood CL, Lane MJ, et al: Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay. Transfusion 1995;35:845-849.
183. Slade BA, Grindon AJ: HCV 2.0: The next generation. Transfusion 1992;32(suppl):S73.
184. Cyrus S, Swenson S, Dembowski J: Removal of HCV infected donors with use of second generation anti-HCV ELISA. Transfusion 1992;32(suppl):S73.
185. Aach RD, Stevens CE, Hollinger FB, et al: Hepatitis C virus infection in post-transfusion hepatitis: An analysis with first and second generation assays. N Engl J Med 1991;325:1325-1329.
186. Vrielink H, van der Poel CL, Reesink HW, et al: Transmission of hepatitis C virus by anti-HCV negative blood transfusion. Vox Sang 1995;68:55-56.
187. Kitchen AD, Wallis PA, German AM: Donor-to-donor and donor-to-patient transmission of hepatitis C virus. Vox Sang 1996;70:112-113.
188. Van der Poel CL, Reesink HW, Cuypers HTM, et al: Is anti-HCV blood donor screening useful? Lancet 1990;336:1193.
189. Ebeling F, Naukkarinen R, Leikola J: Post-transfusion hepatitis C in Finland.Transfus Med 1991; 1:109-113.
190. Ebeling F: Second generation RIBA to confirm diagnosis of HCV infection. Lancet 1991;337: 912-913.
191. Barrera JM, Bruguera M, Ercilla MG, et al: Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med 1991;115: 596-600.
192. Widell A: Antibody to hepatitis C virus related proteins in sera from alanine aminotransferase screened blood donors and prospectively studied recipients. Vox Sang 1991;60:28-33.
193. Van der Poel CL: ALT testing in prospective European trials. Proceedings Regional ISBT Meeting, Venice, 1995.
194. Busch MP, Korelitz JJ, Kleinman SH, et al: Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study. Transfusion 1995;35:903-910.
195. Wolff C, Kleesiek K, Petersen N, Beyer J: Hepatitis C viremia in German blood donors: Serum alanine aminotransferase is not a valid marker for screening. Transfusion 1994;34:361-362.
196. Caspari G, Gerlich WH, Beyer J, Schmitt H: Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors. Infusionsther Transfusionsmed 1995;22:208-219.
197. Sugg U, Schenzle D, Hess G: Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients. Transfusion 1988;28: 386-388.
198. Hetland G, Skaug K, Meland A, et al: Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels. Transfusion 1990;30:776-779.
199. Lin-Chu M, Tsai SJL, Watanabe J, et al: The prevalence of anti-HCV among Chinese voluntary blood donors in Taiwan. Transfusion 1990;30:471-473.
200. Richards C, Holland P, Kuramoto K, et al: Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion 1991;31:109-113.
201. Menitove JE, Richards WA, Destree M: Early US experience with anti-HCV kit in blood donors. Lancet 1990;336:244-245.
202. Korelitz JJ, Busch MP, Kleinman SH, et al: Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors. Transfusion 1996;36:232-237.
203. Inaba S, Fukuda M, Okochi K, et al: HCV transmission after receiving anti-c100-negative blood units. Lancet 1991;337:1354.
204. Donahue JG, Munoz A, Ness PM, et al: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-373.
205. Riggert J, Schwartz DWM, Uy A, et al: Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany. Ann Hematol 1996;72:35-39.
206. Mannucci PM, Zanetti AR, Colombo M, et al: Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. Thromb Haemost 1990;64:232-234.
207. Schulman S, Lindgren AC, Petrini P, et al: Transmission of hepatitis C with pasteurised factor VIII. Lancet 1992;340:305-306.
208. Mosley JW: Transmission of hepatitis C by pasteurised factor VIII. Lancet 1992;340:1160-1161.
209. Kreutz W, Auerswald G, Brückmann C, et al: Prevention of hepatitis C virus infection in children with hemophilia A and B and von Willebrand's disease. Thromb Haemost 1992;67:184.
210. Manucci PM, Schimpf K, Abe LM, et al: Low risk of viral infection after administration of vapor-heated factor VIII concentrate. Transfusion 1992;32:134-138.
211. Noel L, Guerois C, Maissoneuve P, et al: Antibodies to hepatitis C virus in haemophilia. Lancet 1989;ii:560.
212. Skidmore SJ, Pasi KJ, Mawson SJ, et al: Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis. J Med Virol 1990;30:50-52.
213. Manucci PM, Schimpf K, Brettler DB, et al: Low risk for hepatitis C in haemophiliacs given a high-purity, pasteurized factor VIII concentrate. Ann Intern Med 1990;113:27-32.
214. Lefrere JJ, Loiseau P, Martinot-Peignoux M, et al: Infection by hepatitis C virus through contaminated intravenous immune globulin: Results of a prospective national inquiry in France. Transfusion 1996;36:394-397.
215. Yap PL: The viral safely of intravenous immune globulin. Clin Exp Immunol 1996;104(suppl 1): 35-42.
216. Farci P, Alter HJ, Govindarajan S, et al: Lack of protective immunity against reinfection with hepatitis C virus. Science 1991;258:135-140.
217. Rosa D, Campagnol S, Moretto C, et al: A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci 1996;93:1759-1763.